All aboard the KEVLARx bullet train! Destination: head and neck cancer (HNC) without a stop, hopefully, at severe oral mucositis.
En route over the following week, as a quick, handy reference, watch for a series of “bullet blogs” with fast facts on RRx-001 (nibrozetone) and the KEVLARx clinical trial.
These are for anyone with “vested” interest in HNC and severe oral mucositis.
Don’t blink or you’ll miss them.